Genmab’s chief executive retires

Tuesday 15 June 2010

Genmab A/S, which develops antibodies for cancer, announced on 15 June 2010 the retirement of its chief executive, Lisa Drakeman, who has served in that post since the Danish company was founded in 1999.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Denmark